Exelixis



Ebitda تغيير تاريخ
Acadia Pharmaceuticals USD 35.31M 13.07M 2025-06
Agios Pharmaceuticals USD -125797000 20.45M 2025-06
Amgen USD 3.6B 147M 2025-06
AstraZeneca USD 4.96B 127M 2025-06
Bayer EUR 236M 3.35B 2025-06
BioMarin Pharmaceutical USD 295.45M 49.49M 2025-06
Bristol-Myers Squibb USD 3.27B 1.63B 2025-06
Cytokinetics USD -153331000 16.67M 2025-03
Eisai JPY 8.81B 28.8B 2025-03
Eli Lilly USD 7.5B 3.34B 2025-06
Exelixis USD 220.92M 26.71M 2025-06
Genmab DKK 376M 172M 2025-06
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Incyte USD 581.52M 358.87M 2025-06
Ionis Pharmaceuticals USD 150.23M 291.7M 2025-06
MacroGenics USD -50784000 106.81M 2024-12
Merck USD 7.74B 625M 2025-03
Moderna USD -760000000 164M 2025-06
Neurocrine Biosciences USD 152.9M 121.6M 2025-06
Novartis USD 6.17B 339M 2025-06
Pfizer USD 5.32B 889M 2025-06
Sanofi EUR 563M 3.93B 2024-12
Takeda JPY 366.2B 238.06B 2025-06
Ultragenyx Pharmaceutical USD -91344000 35.09M 2025-06
Xencor USD -30519000 6.39M 2025-06


Exelixis - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.